2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein, C. Noel Bairey Merz, Conrad B. Blum, Robert H. Eckel, Anne C. Goldberg, David Gordon, Daniel Levy, Donald M. Lloyd‐Jones, Patrick E. McBride, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Karol E. Watson, Peter W.F. Wilson
Journal of the American College of Cardiology
November 12, 2013
10.1016/j.jacc.2013.11.002
Cited by 3,849Open Access
Full Text

Abstract

Related Papers

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
S. Féasson|The Lancet|2002|7k
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|New England Journal of Medicine|1998|5.3k
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group|New England Journal of Medicine|2005|5.1k
Clinical Practice Guidelines We Can Trust
Board on Health Care Services|National Academies Press eBooks|2011|3.1k
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators|New England Journal of Medicine|2006|2.9k